GlassScriptPhysician profile
Tracy Jon Tipton
NPI 1326487588
$2,909.02
in general payments reported to CMS, 2019-2025
33 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $88.16 · 2021: $286 · 2022: $144 · 2023: $471 · 2024: $771 · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,006.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $273.22 | 2023-2025 | Jelmyto |
| Boston Scientific Corporation | $237.76 | 2019-2025 | Rezum Generator |
| Janssen Biotech, INC. | $222.03 | 2019-2025 | Erleada |
| Endo Pharmaceuticals INC. | $204.51 | 2019-2024 | Xiaflex |
| Teleflex LLC | $197.57 | 2021-2025 | Urolift |
| Coloplast Corp | $192.37 | 2019-2025 | |
| Axonics, INC. | $182.16 | 2020-2024 | Axonics |
| Sumitomo Pharma America, INC. | $158.57 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $154.42 | 2024-2025 | Aquabeam System |
| Abbvie INC. | $151.41 | 2019-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $119.40 | 2021 | |
| Endo USA, INC. | $106.63 | 2024-2025 | Xiaflex |
| Angiodynamics, INC. | $82.80 | 2024-2025 | Nanoknife |
| Ferring Pharmaceuticals INC. | $63.40 | 2025 | Adstiladrin |
| Pfizer INC. | $55.34 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $48.77 | 2019 | |
| Convatec INC. | $44.19 | 2025 | |
| Antares Pharma, INC. | $43.82 | 2022 | |
| Myriad Genetic Laboratories, INC. | $43.21 | 2023-2024 | Prolaris |
| Abc Home Medical Supply, INC. | $40.41 | 2024-2025 | |
| Urovant Sciences INC | $39.94 | 2022 | |
| Tolmar, INC. | $29.85 | 2025 | Eligard, Jatenzo |
| Blue Earth Diagnostics | $28.04 | 2025 | Posluma |
| Calyxo, INC. | $26.62 | 2024 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $24.05 | 2025 | |
| Integra Lifesciences Corporation | $21.00 | 2021 | |
| Bioventus LLC | $20.25 | 2019 | |
| Merck Sharp & Dohme LLC | $18.54 | 2025 | Keytruda |
| Profound Medical Corp. | $18.39 | 2025 | Tulsa-Pro |
| Abbott Laboratories | $18.32 | 2023 | Axium |
| Avadel Specialty Pharmaceuticals, LLC | $14.60 | 2019 | |
| Zyla Life Sciences, INC. | $14.52 | 2019 | |
| Novo Nordisk INC | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Tipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.